The city of Champaign, Illinois, currently has 1 active clinical trials seeking participants for Pulmonary Fibrosis research studies.
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Gender:
ALL
Ages:
40 years and above
Trial Updated:
08/05/2025
Locations: WISPer site in Champaign, IL, Champaign, Illinois
Conditions: Idiopathic Pulmonary Fibrosis